Low-dose aspirin and the risk of stroke and intracerebral bleeding in healthy older people: secondary analysis of a randomized clinical trial

GC Cloud, JD Williamson, C Tran, CB Eaton… - JAMA Network …, 2023 - jamanetwork.com
Importance Low-dose aspirin has been widely used for primary and secondary prevention of
stroke. The balance between potential reduction of ischemic stroke events and increased …

Effect of aspirin on cardiovascular events and bleeding in the healthy elderly

JJ McNeil, R Wolfe, RL Woods… - … England Journal of …, 2018 - Mass Medical Soc
Background Aspirin is a well-established therapy for the secondary prevention of
cardiovascular events. However, its role in the primary prevention of cardiovascular disease …

The aspirin in reducing events in the elderly trial: statistical analysis plan

R Wolfe, AM Murray, RL Woods, B Kirpach… - 2018 - journals.sagepub.com
Rationale Aspirin has positive and negative effects on a number of age-related chronic
conditions and there is uncertainty regarding its role in primary prevention in people aged …

Frequency of intracranial hemorrhage with low-dose aspirin in individuals without symptomatic cardiovascular disease: a systematic review and meta-analysis

WY Huang, JL Saver, YL Wu, CJ Lin, M Lee… - JAMA …, 2019 - jamanetwork.com
Importance Use of low-dose aspirin for the primary prevention of cardiovascular events
remains controversial because increased risk of bleeding may offset the overall benefit …

Bleeding risk with long-term low-dose aspirin: a systematic review of observational studies

LA García Rodríguez, M Martín-Pérez, CH Hennekens… - PLoS one, 2016 - journals.plos.org
Background Low-dose aspirin has proven effectiveness in secondary and primary
prevention of cardiovascular events, but is also associated with an increased risk of major …

Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses

RG Hart, JL Halperin, R McBride… - Archives of …, 2000 - jamanetwork.com
Background Aspirin therapy reduces stroke by about 25% for persons with atherosclerotic
vascular disease, but the effect in those without clinically apparent vascular disease is …

Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial

Y Ikeda, K Shimada, T Teramoto, S Uchiyama… - Jama, 2014 - jamanetwork.com
Importance Prevention of atherosclerotic cardiovascular diseases is an important public
health priority in Japan due to an aging population. Objective To determine whether daily …

[HTML][HTML] Effect of aspirin on disability-free survival in the healthy elderly

JJ McNeil, RL Woods, MR Nelson… - … England Journal of …, 2018 - Mass Medical Soc
Background Information on the use of aspirin to increase healthy independent life span in
older persons is limited. Whether 5 years of daily low-dose aspirin therapy would extend …

Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing …

MR Nelson, CM Reid, LJ Beilin, GA Donnan… - Drugs & aging, 2003 - Springer
Low-dose aspirin (acetylsalicylic acid) therapy has been shown to reduce the risk of
vascular events and there is increasing evidence of its potential to reduce the rate of …

Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials

J He, PK Whelton, B Vu, MJ Klag - Jama, 1998 - jamanetwork.com
Context.—Aspirin has been widely used to prevent myocardial infarction and ischemic
stroke but some studies have suggested it increases risk of hemorrhagic stroke. Objective …